Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Barbara Dominguez"'
Autor:
Iktej Singh Jabbal, Saad Sabbagh, Barbara Dominguez, Mira Itani, Mohamed Mohanna, Thomas Samuel, Zeina Nahleh
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 681-687 (2023)
COVID-19 impacted several health services, including cancer-related care. Its implications were significant due to the lapse in hospital resources, compounded by the delays stemming from the economic effects on patients’ jobs and medical coverage.
Externí odkaz:
https://doaj.org/article/036f72e9904c45d9b504791ae30edf49
Autor:
Nadeem Bilani, Fionnuala Crowley, Mohamed Mohanna, Mira Itani, Marita Yaghi, Diana Saravia, Iktej Jabbal, Barbara Dominguez, Hong Liang, Zeina Nahleh
Publikováno v:
Breast, Vol 66, Iss , Pp 49-53 (2022)
The 21-gene recurrence score assay has been validated as a predictive biomarker in early-stage HR+ and HER2-breast cancer. It is not indicated for use in HER2+ disease based on national guidelines. In this study, we assessed the value of 21-gene recu
Externí odkaz:
https://doaj.org/article/31b183a976e840b2bf6ad948193368d5
Autor:
Marita Yaghi, MD, Paul Benedetto, MD, John Greskovich, MD, Roger Haber, MD, Barbara Dominguez, MBA, Hong Liang, PhD, Zeina Nahleh, MD, Rafael Arteta-Bulos, MD
Publikováno v:
JAAD International, Vol 9, Iss , Pp 128-136 (2022)
Using the National Cancer Database, we introduce the findings of a retrospective investigation of the largest cohort of cases with Merkel cell carcinoma (N = 20,829). A decreasing proportion of stage I (P = .0004) and stage II (P = .0065) Merkel cell
Externí odkaz:
https://doaj.org/article/7b85c1e5ca704655af426082264b9cd9
Autor:
Marita Yaghi, MD, Nadeem Bilani, MD, Barbara Dominguez, MBA, Iktej Singh Jabbal, MBBS, Carlos Rivera, MD, Maroun Bou Zerdan, MD, Hong Li, MS, Diana Saravia, MD, Elizabeth Stone, MD, Zeina Nahleh, MD, FACP
Publikováno v:
Breast, Vol 64, Iss , Pp 112-120 (2022)
Purpose: Treatment protocols for invasive lobular breast cancer (ILC) have largely followed those for invasive ductal breast cancer. This study compares treatment outcomes of endocrine therapy versus combined chemo-endocrine therapy in hormone-recept
Externí odkaz:
https://doaj.org/article/3284ef8026af41d2bcb29482e82a292d
Autor:
Marita Yaghi, Nadeem Bilani, Barbara Dominguez, Maroun Bou Zerdan, Hong Li, Diana Saravia, Elizabeth Stone, Zeina Nahleh
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100666- (2023)
Introduction: : Invasive Lobular Breast Cancer (ILC) harbors unique clinicopathologic features. Data on optimal treatment modalities focusing on ILC remain scarce. We aim to investigate the benefit of chemotherapy in early-stage hormone receptor-posi
Externí odkaz:
https://doaj.org/article/8c93816c4a9b416d9972d96451f810e3
Autor:
Nadeem Bilani, Mira Itani, Leah Soweid, Sindu Iska, Tais Bertasi, Raphael Bertasi, Marita Yaghi, Mohamed Mohanna, Barbara Dominguez, Diana Saravia, Evan Alley, Zeina Nahleh, Rafael Arteta-Bulos
Publikováno v:
Clinical Lung Cancer.
Autor:
Iktej Singh Jabbal, Saad Sabbagh, Mira Itani, Barbara Dominguez, Mohamed Mohanna, Valencia Henry, Hong Liang, Diana Saravia, Tiffany George, Zeina Nahleh, Evan Alley, Rafael Arteta-Bulos
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1686
(1) Background: Disparities in cancer treatment and outcomes have long been well-documented in the medical literature. With the eruption of advances in new treatment modalities, the long-existing disparities are now being further uncovered and brough
Autor:
Mira Itani, Yarden Goldman Gollan, Kristin Ezell, Mohamed Mohanna, Saad Sabbagh, Caoimhin Mears, Katrina A Mears, Barbara Dominguez, Doron Feinsilber, Zeina Nahleh
Publikováno v:
Cureus.
Autor:
Marita Yaghi, Nadeem Bilani, Barbara Dominguez, Maroun Bou Zerdan, Hong Li, Diana Saravia, Elizabeth Stone, Zeina Nahleh
Publikováno v:
Cancer treatment and research communications. 34
Invasive Lobular Breast Cancer (ILC) harbors unique clinicopathologic features. Data on optimal treatment modalities focusing on ILC remain scarce. We aim to investigate the benefit of chemotherapy in early-stage hormone receptor-positive (HR+) and h
Autor:
Kimberly A. Forde, David E. Kaplan, Alejandro Mantero, Craig Newcomb, Ezekiel J. Emanuel, Binu John, Cindy Delgado, Peter P. Reese, David S. Goldberg, Barbara Dominguez, Nadine Nuchovich
Publikováno v:
Liver Transplantation. 27:797-807
Patients are prioritized for liver transplantation (LT) under an "urgency-based" system using the Model for End-Stage Liver Disease score. This system focuses solely on waitlist mortality, without considerations of posttransplant morbidity, mortality